Adenosquamous carcinoma of the head and neck is a rare and aggressive tumor, with fewer than 100 cases reported in the world literature to date. We report a case of adenosquamous carcinoma of the oral pharynx arising as a second primary malignancy in a patient being treated for primary gastric MALT (mucosa-associated lymphoid tissue) lymphoma. We also review the literature to assess current treatment and long-term prognosis of this rare tumor.
Introduction
Adenosquamous carcinoma (ASC) of the head and neck is quite rare, with fewer than 100 cases reported in the literature. [1] [2] [3] Th is tumor is characterized histopathologically by the presence of distinct and separate areas of both squamous cell carcinoma and adenocarcinoma within the same tumor. [4] [5] [6] [7] Clinically, ASC presents as a soft -tissue mass arising from or within any of the mucosal surfaces of the head and neck. Th ese tumors typically appear as enhancing soft -tissue masses on computed tomography (CT), and lesions are oft en locally invasive. Th e cellular origin of these tumors is controversial, and many theories have been proposed in the literature.
Th e prognosis is generally considered to be poor for patients with these tumors, with a mean survival rate of 2 to 3 years 8 and an overall 5-year survival rate of 20 to 57% being reported in the world literature. 1, 3, 9, 10 Attempts at improving survival have been fraught with disappointment, with few case reports showing better long-term survival despite aggressive early intervention. In this article we present a new case of ASC of the oral pharynx and review the literature to assess treatment modalities and long-term prognosis. In addition, the evidence regarding the histologic origin of these tumors is assessed.
Case report
A 58-year-old man was referred to the Otolaryngology-Head and Neck Surgery Department at the National Naval Medical Center, Bethesda, Md., for evaluation of an abnormal positron-emission tomography (PET) scan with an uptake of 3.2 standardized uptake values (SUV) in the left jugulodigastric (JD) region. Th e patient initially had presented to the Emergency Department 3 months earlier, aft er a syncopal episode. At that time he was found to have severe anemia (hemoglobin and hematocrit were 10.5 g/dL and 30.6%, respectively).
Th e patient subsequently was evaluated with an upper and lower GI endoscopic exam and was found to have a large mass in the stomach, which was found on biopsy to be B-cell lymphoma, MALT (mucosa-associated lymphoid tissue) type. On physical exam, the patient had a small, palpable node in the left JD region. Contrastenhanced CT of the neck showed an 8-mm JD node without signifi cant adenopathy.
A PET scan was subsequently performed to identify the presence or absence of metastatic disease. Abnormal uptake was seen in two gastrohepatic lymph nodes, as well as in the left JD region, with an SUV of 3.2 g/dL. Th is area of abnormal activity (SUV) corresponded with the 8-mm node seen on the previous CT scan. Th e patient began external-beam radiation therapy for his gastric (MALT) lymphoma and was referred to ENT for evaluation of the 8-mm cervical node.
On the initial ENT exam, the patient reported a several-month history of progressive left oropharyngeal discomfort. He denied weight loss and reported no otalgia, epistaxis, hemoptysis, voice changes, or dysphagia, and no B symptoms. He denied any allergies and was being treated for gastroesophageal refl ux disease with a proton pump inhibitor. His medical history included anemia, gastric ulcer disease, and a newly diagnosed MALT lymphoma. His surgical history included adenotonsillectomy as a child and wrist surgery. Th e patient reported a remote tobacco history, having quit for more than 40 years, and occasional alcohol use.
A complete head and neck exam was performed, including bimanual examination of the oral cavity and pharynx and nasal endoscopy. Th e only abnormality noted on the physical exam was a 1-cm left JD lymph node. Fine-needle aspiration (FNA) was performed in the clinic, but the sample was found to be unsatisfactory for diagnosis. Repeat ultrasound-guided FNA showed lymphoctes. An excisional biopsy of the left JD node (1.5 × 1.0 × 0.8 cm) was performed in the operating room, and fi nal pathology was positive for ASC. Magnetic resonance imaging (MRI) was then performed to assess the presence of a primary malignancy site, which was negative.
One week postoperatively, the patient underwent modifi ed radical left neck dissection and a rigid endoscopic exam of the oropharynx. He was found on manual exam to have a fi rm submucosal lesion in the left lateral oropharynx. Multiple biopsies of the oral cavity and oral pharynx were taken, and the left lateral oropharyngeal wall was positive for ASC. Th e patient then underwent wide local excision of the left oropharynx and base of the tongue. Final pathology was notable for multiple positive margins and perineural invasion.
Th e patient's case was presented at a multidisciplinary tumor board for discussion of his T1N1M0 lateral oropharyngeal wall ASC. Th e patient was provided with both surgical and medical options. He chose combined chemoradiation without additional surgery at that time.
Th e patient completed postoperative chemoradiation therapy with 7,000 cGy and cisplatin. Two months postoperatively, he underwent a PET scan, which was negative. He continues to be disease-free at this time aft er 4 years of close follow-up.
Discussion
ASC of the head and neck is a rare and aggressive tumor. Fewer than 100 cases have been reported in the literature to date. [1] [2] [3] It is characterized histopathologically by the presence of distinct areas of both squamous cell carcinoma and adenocarcinoma within the same tumor and arising from a common histogenesis. [4] [5] [6] [7] Epidemiology. ASC is more common in males, and most patients present in the sixth or seventh decade. No clear causative relationship with tobacco and alcohol use has been reported, but a number of case reports and case series in the literature appear to show a trend toward tobacco and alcohol use with this tumor.
Clinical characteristics. Clinical presentation is based on the site of tumor origin and the extent of disease. Keelawat et al published a review of 70 cases and reported that the larynx was the most common (50%) site of origin. 1 Th e oral cavity and oral pharynx were second (40%), followed by the hypopharynx (8%), nasopharynx (2%), thyroid gland, and nasal cavity. Th ese tumors also may arise outside the head and neck. Th ey are highly aggressive and carry a poor prognosis. Early lymph node metastasis and perineural invasion are common, and these tumors are deeply invasive.
ASC presents as a soft -tissue mass arising from or within the mucosal surfaces of the head and neck. Th ese tumors may be exophytic and friable, or they may arise submucosally. Th e typical appearance on a CT scan is an enhancing soft -tissue mass that oft en infi ltrates locally and may cause destruction of adjacent bone. ASCs demonstrate intermediate intensity on T1-and T2-weighted MRI and show intense enhancement with gadolinium. 11 Histopathology. A defi nitive diagnosis can be made with histopathologic analysis. ASC is characterized by distinct and separate areas of both squamous cell and adenocarcinoma within the tumor mass (fi gure). Distinct glandular areas are formed from ductal structures, with or without the presence of mucous cells. Th e squamous component appears identical to head and neck squamous cell carcinoma and can be well to poorly diff erentiated, with areas of keratinization and keratin pearl formation.
Th e cellular origin of these tumors is controversial; many theories have been reported in the literature. In 1968, Gerughty et al concluded that they arise from the ductal system of submucosal glands based on their observation of the presence of ductal carcinoma in situ in 4 of 10 cases. 2 Other authors have proposed a combined glandular and squamous epithelial origin of these tumors. [12] [13] [14] More recently, a number of authors have presented evidence that ASC arises from the mucosal epithelium.
For example, Abdelsayed et al performed an immunohistochemical analysis of these tumors and presented results supporting a mucosal origin. 12 In summary, they found that the glandular component was positive for low-molecular-weight cytokeratin (CAM5.2) and carcinoembryonic antigen (CEA) most of the time, and the squamous component was largely nonreactive to CAM5.2 and CEA; no mucous cells were found in the squamous component of the tumor. Th ese data have been duplicated and supported by numerous case series. 9, 13, 14 In 2004, Alos et al presented a more detailed histopathologic analysis of 12 cases of ASC. 9 Similar to the fi ndings reported by Abdelsayed et al, the glandular components of the tumor were found to be positive for CAM5.2 and CEA most of the time, and the squamous components were largely nonreactive to these markers. However, cytokeratin 7 was also positive in most of the glandular components and negative in most of the squamous components. Th e glandular and squamous components were positive for high-molecular-weight cytokeratin in 100% of cases and negative for cytokeratin 20 in all cases. 9 Based on these results, the authors concluded that ASC originates from the surface mucosal epithelium of the upper aerodigestive tract.
Diff erential diagnosis. Th e diff erential diagnosis for ASC includes mucoepidermoid carcinoma (MEC), adenoid squamous carcinoma (AdSC), basaloid squamous carcinoma (BSC), and squamous cell carcinoma (SCC). MEC is characterized by inseparable (mixed) areas of squamous and glandular elements, with a normal surface epithelium and both transitional and intermediate cells. In order to diagnose MEC, the presence of three distinct cell types-squamous, mucous and intermediate cells-must be confi rmed with histologic analysis of the tumor.
AdSC is characterized by acantholysis and pseudoglandular formations, which contain no mucous cells. Th ese tumors stain negative for mucin.
BSC shows clusters of basaloid cells without a glandular malignant component.
Treatment. Most authors recommend early and aggressive surgical resection for the treatment of ASC. Th is includes aggressive wide local excision or radical surgical excision of the primary lesion with combined neck dissection at the time of presentation. Postoperative radiation therapy is oft en included and is clearly indicated for positive margins, advanced cervical lymph node metastasis, and perineural invasion. Combined chemoradiation is an alternative for poor surgical candidates; however, long-term survival has been poor.
Th e mean survival rate for ASC is 2 to 3 years, 8 and an overall 5-year survival rate of 20 to 57% has been reported in the world literature. 1, 3, 9, 10 Keelawat et al reported a rate of 65 to 75% lymph node metastasis for 70 cases and a 70% local recurrence rate for their own 12 cases. 1 Most authors agree that the prognosis is poor, with very low long-term survival rates. However, some authors have reported better long-term survival following aggressive surgical therapy. 3, 8, 10 For example, Passon et al presented a single case of a patient with a T2N0M0 ASC of the supraglottis that was treated with total laryngectomy and ipsilateral selective neck dissection. 8 Th is patient had a 15-year disease-free survival period. Although this result might have been partly attributable to the relatively sparse lymphatic drainage of the larynx when compared to other head and neck sites, longer survival has been reported for ASC arising in other head and neck sites. 3, 10 In conclusion, ASC is a rare and aggressive malignancy with a poor prognosis. Tumor pathology is characterized by distinct areas of squamous cell carcinoma and adenocarcinoma within the same tumor, with a common cellular histogenesis. Th e cellular origin of these tumors is controversial, and recent immunohistologic data suggest that this tumor arises from the mucosal surface epithelium. Limited case reports suggest pos- Figure. On histopathology, the tumor demonstrates distinct areas of adenocarcinoma and squamous cell carcinoma arising in a single tumor mass. Areas of adenocarcinoma (arrowhead) demonstrate distinct glandular structures. On the right, areas of squamous-cellcarcinoma are seen (arrow), with sheets of epitheliod squamous cells (H&E, original magnifi cation ×200). www.entjournal.com ■ E21 sible improved long-term survival with early aggressive surgical intervention, although survival overall is considered poor.
